Published in Women's Health Weekly, August 26th, 1996
BRCA2, the second breast cancer susceptibility gene, was localized, following the cloning of BRCA1 in 1994. Women with altered versions of these genes have a 70 to 90 percent risk of developing breast cancer, as well as an increased risk of ovarian cancer.
Scientists discovered this year that specific alterations in both BRCA1 and BRCA2 are common in the Ashkenazi Jewish population (Jews of European descent). ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly